SASYA INC

Wayzata, MN · Agritech · Private

Engineered enzymes for synthesis of feed additives from renewable feedstocks

Claim this profile

Follows are private to you and power your alerts

Updated · sasyabio.com

Sector
Agritech
Headquarters
Wayzata, MN
Total capital
$2.3M
Federal grants
$2.3M
6 awards · 2016–2024
Rank in peer group#17 of 27
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
1 pending · first 2024
Rank in peer group#3 of 27

Capital timeline

20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $2.3M$150K$100K$225K$995K$175K$650K
20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $2.3M$225K$995K$175K$650K

Latest events

  • Federal grantAgriculture · ** Awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** In This Project, Sasya Aims To Develop A Tailored Probiotic Strain That Is Capable Of Directly Producing Nutrients In The Gi Tract Of The Host Animal, Where They Are Absorbed. Specifically, We Will Initially Target The US Broiler Feed Market, Mainly Because Of Large Market Size, Dependency On Expensive Ingredients In The Feed For $650K
  • Federal grantAgriculture · Growing Restrictions On Antibiotics And Other Growth Promoters In The Livestock Industry Has Left An Acute Need For Alternative Supplements To Enhance Animal Growth And Prevent Infection. Sasya Aims To Address These Issues By Using Synthetic Biology To Develop A Probiotic Cell Factory To Produce And Deliver Performance Supplements To Livestock. Engineered Probiotics Represent An Alternative Approach With Several Advantages To Traditional Chemical Or Fermentative Synthesis Methods. By Employing A$175K
  • Federal grantNSF · Phase II · SBIR Phase II: Sustainable production of high-performance dietary supplements$995K
  • Federal grantNSF · Phase I · STTR Phase I: Enzyme design for economical feed additives from sugar$225K
  • Federal grantAgriculture · Fishmeal Alternative From Renewable Feedstock$100K
  • Federal grantEnergy · Phase I · Carbon and energy capture from biogas for the production of biochemicals$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 27 peers

Line = median

Agritech · Molecule

  • Federal grantsBelow median
  • Granted patents#3 · top 11%
  • Linked publications#1 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 4
Show all 4 patent records

Recent research by its founders

  • Fishmeal alternative from renewable CO<sub>2</sub>for rainbow trout feed20206 cites
  • Economics of membrane occupancy and respiro‐fermentation2011216 cites
  • Mapping the interaction of Snf1 with TORC1 in Saccharomyces cerevisiae2011194 cites
  • Sasya, LLCShares a founder: Goutham Vemuri
  • CANOMIKS, INC.Similar federal contract value in Agritech · null in contracts
  • TREES ROI LLCSimilar federal contract value in Agritech · null in contracts
  • HEXAS BIOMASS INCSimilar federal contract value in Agritech · null in contracts
  • AKORN INCSimilar federal contract value in Agritech · null in contracts
  • HIVETECH SOLUTIONS INCSimilar federal contract value in Agritech · null in contracts

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .